Atlas Trials

Comparison of Intramuscular Olanzapine and Intramuscular Haloperidol in Patients With Schizophrenia

Clinical trial NCT00485901 · COMPLETED

Trial details

NCT number
NCT00485901
Sponsor
Eli Lilly and Company
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Schizophrenia
Start date
2004-07-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.